An antiparkinsonian agent. A non-ergoline selective agonist of dopamine D2 and D3 receptors. A possible mechanism of action in the treatment of Parkinson's disease , associated with a stimulating effect on the postsynaptic D2 receptors of the basal nuclei in the brain.
Requip
| Package | pill | Total price | Save | Order |
|---|---|---|---|---|
| 2mg × 30 Pills | $3.75 | $112.40 + Bonus - 4 Pills | - | Add to cart |
| 2mg × 60 Pills | $2.74 | $164.11 + Bonus - 4 Pills | $60.60 | Add to cart |
| 2mg × 90 Pills | $2.40 | $215.81 + Bonus - 7 Pills Free Trackable Delivery | $121.50 | Add to cart |
| 2mg × 120 Pills | $2.23 | $267.52 + Bonus - 7 Pills Free Trackable Delivery | $182.40 | Add to cart |
| 2mg × 180 Pills | $2.06 | $370.93 + Bonus - 11 Pills Free Trackable Delivery | $304.20 | Add to cart |
| Package | pill | Total price | Save | Order |
|---|---|---|---|---|
| 1mg × 30 Pills | $2.32 | $69.53 + Bonus - 4 Pills | - | Add to cart |
| 1mg × 60 Pills | $1.87 | $112.49 + Bonus - 4 Pills | $27.00 | Add to cart |
| 1mg × 90 Pills | $1.73 | $155.48 + Bonus - 7 Pills | $53.10 | Add to cart |
| 1mg × 120 Pills | $1.65 | $198.45 + Bonus - 7 Pills | $80.40 | Add to cart |
| 1mg × 180 Pills | $1.58 | $284.41 + Bonus - 11 Pills Free Trackable Delivery | $133.20 | Add to cart |
| 1mg × 270 Pills | $1.53 | $413.33 + Bonus - 11 Pills Free Trackable Delivery | $213.30 | Add to cart |
| 1mg × 360 Pills | $1.51 | $542.27 + Bonus - 11 Pills Free Trackable Delivery | $291.60 | Add to cart |
| Package | pill | Total price | Save | Order |
|---|---|---|---|---|
| 0.25mg × 60 Pills | $0.86 | $51.78 + Bonus - 4 Pills | - | Add to cart |
| 0.25mg × 90 Pills | $0.72 | $64.63 + Bonus - 7 Pills | $12.60 | Add to cart |
| 0.25mg × 180 Pills | $0.57 | $103.16 + Bonus - 11 Pills | $52.20 | Add to cart |
| 0.25mg × 360 Pills | $0.50 | $180.22 + Bonus - 11 Pills | $129.60 | Add to cart |
| Package | pill | Total price | Save | Order |
|---|---|---|---|---|
| 0.5mg × 60 Pills | $1.04 | $62.26 + Bonus - 4 Pills | - | Add to cart |
| Package | pill | Total price | Save | Order |
|---|---|---|---|---|
| 0.5bottles × 30 Pills | $1.33 | $39.83 + Bonus - 4 Pills | - | Add to cart |
| Package | pill | Total price | Save | Order |
|---|---|---|---|---|
| 0,5mg × 90 Pills | $0.94 | $84.72 + Bonus - 7 Pills | - | Add to cart |
| 0,5mg × 120 Pills | $0.89 | $107.15 + Bonus - 7 Pills | $6.00 | Add to cart |
| 0,5mg × 180 Pills | $0.84 | $152.06 + Bonus - 11 Pills | $18.00 | Add to cart |
| 0,5mg × 270 Pills | $0.81 | $219.38 + Bonus - 11 Pills Free Trackable Delivery | $35.10 | Add to cart |
| 0,5mg × 360 Pills | $0.80 | $286.71 + Bonus - 11 Pills Free Trackable Delivery | $50.40 | Add to cart |
Your order will be packed safely and securely and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has the size and the look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm), and it does not disclose its contents
Requip Product Description
Drug Uses
Requip is a non-ergoline dopamine agonist, stimulating striatal dopamine receptors and improving the chemical imbalance in the brain affected by Parkinson's disease. This drug provides an effect in the hypothalamus and pituitary by inhibiting the prolactin secretion.
Requip is indicated to adults for treatment of Parkinson's disease symptoms as monotherapy or in combination with levodopa. The application of the antiparkinson drug can delay administration of levodopa.
In addition, Requip may also be administered for treatment of moderate-to-severe primary restless legs syndrome. This neurological disorder is characterized by unpleasant sensations in the legs, often appearing during the night.
An initial recommended dose of Requip is 0.75 mg per day (one 0.25 mg tablet of Requip three times a day) for 7 days. Then the daily dose is to be increased, taking into account the tolerance to the antiparkinson drug and the therapeutic response. The maximum Requip dose should not exceed 24 mg per day.
Missed Dose
If the patient had missed the dose of Requip, s/he must skip the tablet in case if it is close to the next scheduled dose of this antiparkinsonian agent. If it is enough time till the next dose of Requip, the patient can use a tablet immediately as it possible.
More Information
When Requip is prescribed as an adjunct to levodopa therapy, the daily dose of levodopa is recommended to be reduced. This will help avoid excessive dopamine stimulation and development of side effects. Levodopa dosage should be decreased gradually.
Storage
Recommended temperature for Requip storage is from 20°C to 25°C. Keep the tablets in a warm dry place in a tightly closed bottle.
Requip Safety Information
Warnings
Requip may cause sudden sleep attacks and daytime sleepiness. The patients feeling sleepy should be advised not to drive a motor vehicle or operate machinery. In order to reduce the risk of sudden sleep attacks, the daily dose of the antiparkinson drug should be decreased. If cases of sudden onset of sleep are failed to be minimized, it is recommended to stop taking Requip and to consider alternative treatments for Parkinson's disease.
Disclaimer
All the information about Parkinson's Disease, which is included in the review of Requip, is published for general information purpose only, and should not be taken as a substitute for professional advice of the qualified medical professional. The online pharmacy shall disclaim any responsibility for any kind of consequences, including damage or loss, which may follow from the use of information about antiparkinsonian agent, Requip.
Requip Side Effects
The most common adverse events, caused by Requip, include vomiting, heartburn, nausea, syncope, dizziness, abdominal pain, dyskinesia. They usually appear at the beginning of the treatment with the antiparkinsonian agent, are mild, and rarely result in withdrawal of Requip. Less commonly, the antiparkinsonian drug may cause other adverse events, such as leg edema, sweating, confusion, dyspepsia, hallucinations, viral infection, somnolence, headache or asthenic condition. The intensity and frequency of Requip adverse events can be reduced by lowering the dose.
Endep - tricyclic antidepressant. The mechanism of antidepressive action is connected with increase in concentration of noradrenaline in synapses and/or serotonin in CNS (decrease in return absorption). Accumulation of these neurotransmitters results from inhibition of their return capture by membranes of presynaptic neurons.
Brand Levitra – a drug from Bayer, with a basic chemical called Vardenafil, is an improved remedy for treating erectile difficulties. Operates approximately within 6-8 hours, so a man may be ready to perform sexually the whole night.
Viagra Super Active - an innovative formula of drug for treatment of erectile dysfunction. Drug is produced in gelatin capsules that allows to avoid emergence of heartburn or other unpleasant feelings in a stomach. Sildenafil Super Active also has a number of advantages. It is soaked quicker and works longer. The principle of action is identical with ordinary Sildenafil. Each capsule contains about 100 mg of active ingredient. That is quite enough for any man.
Actos, which is pioglitazone - is prescribed to patients with diabetes of type 2 (both as monotherapy, and in a form of the combined therapy with sulphonylurea, metformin or insulin as additional medicine to dietotherapy and physical exercises). Pioglitazone represents peroral hypoglycemic medicine of Thiazolidinediones alignment which effect depends on insulin presence. It is a high-selective agonist of gamma receptors, activated by proliferator of peroxysom (PPAR-γ).
Flagyl - antiprotozoan and antimicrobic drug. It is prescribed at treatment of protozoan inspections (abenteric amebiasis, including amoebic abscess of liver, an intestinal amebiasis, trichomoniasis, giardiasis, balanthidiasis, lambliasis, skin leushmaniosis, mecotic vaginitis, mecotic urethritis), pseudomembranous colitis, gastritises, ulcer, prevention of postoperative complications (especially interventions at segmented intestine, perirectal area, appendectomy, gynecologic operations).
Cefixime is a medicine intended for the treatment of acute and chronic bronchitis, bacterial bronchitis, middle ear inflammation, pharyngitis and tonsillitis, bacterial infections of the urinary tract, cystitis, urethritis, pyelonephritis, cerivitis.
A thiazide diuretic of the average intensity, applied in arterial hypertension, edema syndrome of different origin, gestosis and diabetes insipidus. Reduces reabsorption of Na+ at the level of the Henle loop cortical segment, without affecting its segment lying in the medulla of the kidney that detects a weaker diuretic effect compared with furosemide.
Levitra - the main component - the active agent Vardenafil which promotes strengthening of blood circulation in generative organs of men. It allows to reach a high level erection at sexual stimulation, and also to increase sensitivity of head of a penis and to make sexual intercourse longer and more pleasant. The main feature of a drug Levitra - quickness of effect, duration of impact on an organism up to 12 hours and a very small number of side effects.
Antiemetic, which is a specific blocker of dopamine (D2) and serotonin receptors. It has antiemetic effect, eliminates nausea and hiccups. Reduces moving activity of the esophagus, increases the tone of the lower esophageal sphincter, accelerates gastric emptying and the movement of food through the small intestine without causing diarrhea. Stimulates the secretion of prolactin.
Strattera - the drug with an international non-proprietary name of the active substance - Atomoxetine, it is intended as a sympathomimetic agent for the prevention and treatment of attention deficit hyperactivity disorder (ADHD) in children 6 years of age and older, adolescents and adults.
Cefaclor is a medicine used to treat the symptoms of various bacterial infections such as Bronchitis, Pharyngitis and Tonsillitis, Urinary Tract Infection, Ear Infections (Otitis Media) and Lower Respiratory Tract Infections. Cefaclor may be used alone or with other medications.
